Evolving strategies for prostate cancer chemoprevention trials (Q35102224)

6 August 2017

Evolving strategies for prostate cancer chemoprevention trials (English)

1 reference

6 August 2017

1 reference

Ronald Lieberman

1

1 reference

6 August 2017

1 April 2003

1 reference

6 August 2017

World Journal of Urology

1 reference

6 August 2017

21

1 reference

6 August 2017

1

1 reference

6 August 2017

3-8

1 reference

https://scigraph.springernature.com/pub.10.1007/s00345-003-0317-4

6 August 2017

0 references

cites work

Vegetables, fruit, and cancer. I. Epidemiology

1 reference

12 December 2020

The molecular pathogenesis of prostate cancer: Implications for prostate cancer prevention.

1 reference

12 December 2020

Chemoprevention: an essential approach to controlling cancer

1 reference

12 December 2020

Germline mutations in the ribonuclease L gene in families showing linkage with HPC1

1 reference

12 December 2020

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

1 reference

12 December 2020

Serum proteomic patterns for detection of prostate cancer

1 reference

12 December 2020

Cloning, legislation and human welfare

1 reference

12 December 2020

Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study

1 reference

12 December 2020

Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.

1 reference

12 December 2020

SELECT: the next prostate cancer prevention trial. Selenum and Vitamin E Cancer Prevention Trial.

1 reference

12 December 2020

Androgen deprivation therapy for prostate cancer chemoprevention: current status and future directions for agent development

1 reference

12 December 2020

Progress in prostate cancer chemoprevention: modulators of promotion and progression

1 reference

12 December 2020

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

1 reference

12 December 2020

Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia

1 reference

12 December 2020

Design considerations for efficient prostate cancer chemoprevention trials.

1 reference

12 December 2020

Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis

1 reference

12 December 2020

Molecular effects of the herbal compound PC-SPES: identification of activity pathways in prostate carcinoma.

1 reference

12 December 2020

The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients

1 reference

12 December 2020

Prostate Cancer and Supplementation With α-Tocopherol and β-Carotene: Incidence and Mortality in a Controlled Trial

1 reference

12 December 2020

Trial endpoints for drug approval in oncology: Chemoprevention

1 reference

12 December 2020

Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.

1 reference

12 December 2020

Approaches to the development and marketing approval of drugs that prevent cancer.

1 reference

12 December 2020

Acetylation in hormone signaling and the cell cycle

1 reference

12 December 2020

Design of the Prostate Cancer Prevention Trial (PCPT).

1 reference

12 December 2020

Prostate cancer chemoprevention: Strategies for designing efficient clinical trials

1 reference

12 December 2020

10.1007/S00345-003-0317-4

Identifiers

DOI

0 references

PubMed ID

12682772

1 reference

PubMed ID

12682772